Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1921 1
1928 1
1929 1
1932 1
1938 1
1940 1
1941 1
1942 1
1943 1
1945 1
1947 1
1948 3
1949 6
1950 6
1951 6
1952 7
1953 7
1954 5
1955 6
1956 4
1957 3
1958 7
1959 12
1960 4
1961 7
1962 6
1963 20
1964 24
1965 17
1966 10
1967 12
1968 12
1969 9
1970 18
1971 10
1972 12
1973 13
1974 23
1975 39
1976 40
1977 38
1978 50
1979 53
1980 56
1981 65
1982 70
1983 92
1984 122
1985 112
1986 122
1987 127
1988 152
1989 141
1990 170
1991 183
1992 211
1993 173
1994 218
1995 220
1996 268
1997 297
1998 366
1999 351
2000 483
2001 558
2002 619
2003 644
2004 710
2005 776
2006 875
2007 945
2008 982
2009 1068
2010 1251
2011 1325
2012 1598
2013 1704
2014 1858
2015 1943
2016 2076
2017 2235
2018 2211
2019 2410
2020 2223
2021 17
Text availability
Article attribute
Article type
Publication date

Search Results

29,269 results
Results by year
Filters applied: . Clear all
Page 1
Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review.
Mokbel K, Mokbel K. Mokbel K, et al. In Vivo. 2019 Jul-Aug;33(4):983-997. doi: 10.21873/invivo.11568. In Vivo. 2019. PMID: 31280187 Free PMC article. Review.
There is sufficient evidence from in vitro, animal and epidemiological human studies that certain vitamins, such as vitamin D3, folate, vitamin B6, and beta carotene as well as dietary micronutrients, such as curcumin, piperine, sulforaphane, indole-3-carbinol, querceti
There is sufficient evidence from in vitro, animal and epidemiological human studies that certain vitamins, such as vitamin D3, folate, vita …
Curcumin targets in inflammation and cancer.
Deguchi A. Deguchi A. Endocr Metab Immune Disord Drug Targets. 2015;15(2):88-96. doi: 10.2174/1871530315666150316120458. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 25772169 Review.
Accumulating evidence suggests that curcumin has several pharmacologic effects, including anti-inflammatory, anti-oxidant and anti-cancer activities. ...Thus, curcumin is one of the most promising phytochemicals that target various cancers and inflammation-me …
Accumulating evidence suggests that curcumin has several pharmacologic effects, including anti-inflammatory, anti-oxidant and anti- …
Curcumin in Treating Breast Cancer: A Review.
Wang Y, Yu J, Cui R, Lin J, Ding X. Wang Y, et al. J Lab Autom. 2016 Dec;21(6):723-731. doi: 10.1177/2211068216655524. Epub 2016 Jun 20. J Lab Autom. 2016. PMID: 27325106 Review.
Curcumin, an active derivative from turmeric, has been reported to have anticancer and chemoprevention effects on breast cancer. ...Experimental evidence has shown that curcumin also regulates apoptosis and cell phase-related genes and microRNA in b
Curcumin, an active derivative from turmeric, has been reported to have anticancer and chemoprevention effects on breast ca
Liposomal curcumin and its application in cancer.
Feng T, Wei Y, Lee RJ, Zhao L. Feng T, et al. Int J Nanomedicine. 2017 Aug 21;12:6027-6044. doi: 10.2147/IJN.S132434. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28860764 Free PMC article. Review.
Curcumin (CUR) is a yellow polyphenolic compound derived from the plant turmeric. It is widely used to treat many types of diseases, including cancers such as those of lung, cervices, prostate, breast, bone and liver. ...Liposomal CUR formulation has greater growth
Curcumin (CUR) is a yellow polyphenolic compound derived from the plant turmeric. It is widely used to treat many types of diseases,
Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z, Khwaza V, Aderibigbe BA. Mbese Z, et al. Molecules. 2019 Nov 30;24(23):4386. doi: 10.3390/molecules24234386. Molecules. 2019. PMID: 31801262 Free PMC article. Review.
Curcumin, a phenolic compound originally derived from turmeric plant (Curcuma longa L. (Zingiberaceae family)) widely known as a spice and a coloring agent for food have been reported to possess notable anticancer activity by inhibiting the proliferation and metastasis, an
Curcumin, a phenolic compound originally derived from turmeric plant (Curcuma longa L. (Zingiberaceae family)) widely known as a spic
Molecular targets of curcumin in breast cancer (Review).
Song X, Zhang M, Dai E, Luo Y. Song X, et al. Mol Med Rep. 2019 Jan;19(1):23-29. doi: 10.3892/mmr.2018.9665. Epub 2018 Nov 19. Mol Med Rep. 2019. PMID: 30483727 Review.
Clinical studies have demonstrated that curcumin alone or combined with other drugs exhibits promising anticancer activity in patients with breast cancer without adverse effects. In the present review, the chemistry and bioavailability of curcumin and …
Clinical studies have demonstrated that curcumin alone or combined with other drugs exhibits promising anticancer activity in patient …
Curcumin and cancer: barriers to obtaining a health claim.
Devassy JG, Nwachukwu ID, Jones PJ. Devassy JG, et al. Nutr Rev. 2015 Mar;73(3):155-65. doi: 10.1093/nutrit/nuu064. Epub 2015 Feb 13. Nutr Rev. 2015. PMID: 26024538 Review.
Curcumin has been shown to modulate multiple cell-signaling pathways simultaneously, thereby mitigating or preventing many different types of cancers, including multiple myeloma and colorectal, pancreatic, breast, prostate, lung, head, and neck cancers, in both anim
Curcumin has been shown to modulate multiple cell-signaling pathways simultaneously, thereby mitigating or preventing many different
Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines.
Kundur S, Prayag A, Selvakumar P, Nguyen H, McKee L, Cruz C, Srinivasan A, Shoyele S, Lakshmikuttyamma A. Kundur S, et al. J Cell Physiol. 2019 Jul;234(7):11103-11118. doi: 10.1002/jcp.27761. Epub 2018 Nov 27. J Cell Physiol. 2019. PMID: 30478904
Women with the breast cancer type 1 susceptibility protein (BRCA1) mutation and loss of BRCA1 expression are reported to have an increased risk of triple-negative breast cancer (TNBC). ...Our studies detected that BRCA1 is poorly expressed in TNBC cell …
Women with the breast cancer type 1 susceptibility protein (BRCA1) mutation and loss of BRCA1 expression are reported to have …
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
Dandawate PR, Subramaniam D, Jensen RA, Anant S. Dandawate PR, et al. Semin Cancer Biol. 2016 Oct;40-41:192-208. doi: 10.1016/j.semcancer.2016.09.001. Epub 2016 Sep 5. Semin Cancer Biol. 2016. PMID: 27609747 Free PMC article. Review.
Breast cancer is the most common form of cancer diagnosed in women worldwide and the second leading cause of cancer-related deaths in the USA. ...Therefore, in the present review article, we summarize our current understanding of breast CSCs and
Breast cancer is the most common form of cancer diagnosed in women worldwide and the second leading cause of cancer
Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM, Ponce-Cusi R, Carrión F. Calaf GM, et al. Oncol Rep. 2018 Oct;40(4):2381-2388. doi: 10.3892/or.2018.6603. Epub 2018 Jul 26. Oncol Rep. 2018. PMID: 30066930
Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer that exerts antitumor activity in numerous types of cancer cell. ...It was demonstrated that the combined treatment with curcumin and paclitaxel resulted in a higher l …
Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer that exerts antitumor activity in numerou …
29,269 results
Jump to page
Feedback